Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
JetBlue
JBLU
$2.19B
| $4.99M | 0.01% |
242,201
-4,008,099
| -94% | -$81.7M |
|
1677
Century Casinos
CNTY
$35.2M
| $4.98M | 0.01% |
658,200
+48,800
| +8% | +$354K |
|
1678
Wabash National
WNC
$509M
| $4.97M | 0.01% |
+240,000
| New | +$4.7M |
|
1679
Bankwell Financial Group
BWFG
$542M
| $4.96M | 0.01% |
144,296
+10,696
| +8% | +$337K |
|
1680
Blue Bird Corp
BLBD
$2.05B
| $4.96M | 0.01% |
289,200
+16,600
| +6% | +$276K |
|
1681
IQVIA
IQV
$39.8B
| $4.96M | 0.01% |
+61,557
| New | +$4.8M |
|
|
POLY
1682
DELISTED
Plantronics, Inc.
POLY
| $4.96M | 0.01% |
91,600
+14,900
| +19% | +$811K |
|
|
LAND
1683
Gladstone Land Corp
LAND
$358M
| $4.95M | 0.01% |
445,700
+68,800
| +18% | +$812K |
|
1684
Shore Bancshares
SHBI
$799M
| $4.93M | 0.01% |
295,100
+26,400
| +10% | +$434K |
|
1685
First Bancorp
FNLC
$401M
| $4.93M | 0.01% |
180,823
+23,223
| +15% | +$642K |
|
1686
Columbia Banking Systems
COLB
$9.18B
| $4.92M | 0.01% |
+126,079
| New | +$5.08M |
|
|
SHI
1687
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $4.92M | 0.01% |
88,150
+63,100
| +252% | +$3.77M |
|
|
OMED
1688
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $4.91M | 0.01% |
533,600
+64,300
| +14% | +$565K |
|
1689
Unifirst Corp
UNF
$5.21B
| $4.89M | 0.01% |
34,600
-10,700
| -24% | -$1.41M |
|
|
MOBL
1690
DELISTED
MobileIron, Inc.
MOBL
| $4.89M | 0.01% |
1,125,000
+211,500
| +23% | +$936K |
|
|
ORBC
1691
DELISTED
ORBCOMM, Inc.
ORBC
| $4.87M | 0.01% |
509,786
+405,286
| +388% | +$3.48M |
|
1692
Standex International
SXI
$3.97B
| $4.87M | 0.01% |
48,600
-9,600
| -16% | -$900K |
|
|
NAME
1693
DELISTED
Rightside Group, Ltd.
NAME
| $4.87M | 0.01% |
490,605
-13,200
| -3% | -$115K |
|
|
NP
1694
DELISTED
Neenah, Inc. Common Stock
NP
| $4.86M | 0.01% |
65,000
+13,500
| +26% | +$1.07M |
|
1695
AXT Inc
AXTI
$5.07B
| $4.85M | 0.01% |
835,860
-82,974
| -9% | -$515K |
|
|
PDS
1696
Precision Drilling
PDS
$1.06B
| $4.84M | 0.01% |
51,243
+31,711
| +162% | +$3.32M |
|
1697
Conagra Brands
CAG
$7.39B
| $4.83M | 0.01% |
119,800
-129,100
| -52% | -$5.15M |
|
|
SYNC
1698
DELISTED
Synacor, Inc.
SYNC
| $4.82M | 0.01% |
1,160,600
+16,400
| +1% | +$53.1K |
|
1699
German American Bancorp
GABC
$1.92B
| $4.81M | 0.01% |
152,550
+38,100
| +33% | +$1.23M |
|
1700
Hyatt Hotels
H
$16.9B
| $4.8M | 0.01% |
89,000
-312,800
| -78% | -$16.9M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.